Nitrofurantoin-induced lung disease and prophylaxis of urinary tract infections

Primary Care Respiratory Journal

Volumn 21, Issue 3, 2012, Pages 337-341

  Madani, Yasser ^a   Mann, Bhupinder ^a  

^a WEST MIDDLESEX UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Drug induced; Fibrosis; Lung disease; Nitrofurantoin; Prophylaxis; Urinary tract infection

Indexed keywords

NITROFURANTOIN; OXYGEN; PREDNISOLONE;

AGED; ARTERIAL GAS; ARTICLE; BLOOD CARBON DIOXIDE TENSION; BLOOD OXYGEN TENSION; BREATHING RATE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONNECTIVE TISSUE DISEASE; COUGHING; DRUG WITHDRAWAL; DYSPNEA; EOSINOPHIL COUNT; EXERCISE TOLERANCE; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; HUMAN CELL; INFECTION PREVENTION; INTERSTITIAL LUNG DISEASE; LONG TERM CARE; LUNG ARTERY PRESSURE; LUNG AUSCULTATION; LUNG FUNCTION TEST; LUNG TRANSFER FACTOR; MALE; MEDICAL HISTORY; OXYGEN SATURATION; OXYGEN THERAPY; PH; RECURRENT INFECTION; THORAX RADIOGRAPHY; TOTAL LUNG CAPACITY; URINARY TRACT INFECTION;

AGED, 80 AND OVER; ANTI-INFECTIVE AGENTS, URINARY; FEMALE; HUMANS; LUNG DISEASES; MALE; MIDDLE AGED; NITROFURANTOIN; URINARY TRACT INFECTIONS;

EID: 84866344908     PISSN: 14714418     EISSN: 14751534     Source Type: Journal    
DOI: 10.4104/pcrj.2012.00059     Document Type: Article

References (21)

1. Israel KS, Brashear RE, Sharma HM, Yum MN, Glover JL. Pulmonary fibrosis and nitrofurantoin. Am Rev Respir Dis 1973;108(2):353-6.
2. Holmberg L, Boman G, Bottiger LE, Eriksson B, Spross R, Wessling A. Adverse reactions to nitrofurantoin. Analysis of 921 reports. Am J Med 1980;69:733-8. http://dx.doi.org/10.1016/0002-9343(80)90443-X
3. Holmberg L, Boman G. Pulmonary reactions to nitrofurantoin. 447 cases reported to the Swedish Adverse Drug Reaction Committee 1966-1976. Eur J Respir Dis 1981;62:180-9.
4. Fisk AA. Brief recording: anaphylactoid reaction to nitrofurantoin. N Engl J Med 1957;256(22):1054. http://dx.doi.org/10.1056/NEJM195705302562207
5. Rosenow EC 3rd, DeRemee RA, Dines DE. Chronic nitrofurantoin pulmonary reaction. Report of 5 cases. N Engl J Med 1968;279(23):1258-62. http://dx.doi.org/10.1056/NEJM196812052792304
6. Hainer BL, White AA: Nitrofurantoin pulmonary toxicity. J Fam Pract 1981;13(6):817-23.
7. Boggess KA, Benedetti TJ, Raghu G: Nitrofurantoin-induced pulmonary toxicity during pregnancy: a report of a case and review of the literature. Obstet Gynecol Surv 1996;51(6):367-70. http://dx.doi.org/10.1097/00006254-199606000-00021
8. Witten CM. Pulmonary toxicity of nitrofurantoin. Arch Phys Med Rehabil 1989;70(1):55-7.
9. Krause M, Ruef C. Miscellaneous antibacterial drugs. In: Dukes MNG, Aronson KH, ed. Meyler's Side Effects of Drugs. 14th ed. Amsterdam: Elsevier BV, 2000. p.884-5.
10. Bhullar S, Lele SM, Kraman S. Severe nitrofurantoin lung disease resolving without the use of steroids. J Postgrad Med 2007;53(2):111-13. http://dx.doi.org/10.4103/0022-3859.32211
11. Martins RR, Marchiori E, Viana SL, Grillo Júnior LS, Capelozzi VL, Valença LM. Chronic eosinophilic pneumonia secondary to long-term use of nitrofurantoin: highresolution computed tomography findings. J Bras Pneumol 2008;34(3):181-4. http://dx.doi.org/10.1590/S1806-37132008000300009
12. Mendez JL, Nadrous HF, Hartman TE, Ryu JH. Chronic nitrofurantoin-induced lung disease. Mayo Clin Proc 2005;80(10):1298-302. http://dx.doi.org/10.4065/80.10.1298
13. Goemaere NN, Grijm K, van Hal PT, den Bakker MA. Nitrofurantoin-induced pulmonary fibrosis: a case report. J Med Case Reports 2008;21(2):169. http://dx.doi.org/10.1186/1752-1947-2-169
14. Willcox PA, Maze SS, Sandler M, Benatar SR. Pulmonary fibrosis following long-term nitrofurantoin therapy. S Afr Med J 1982;61(19):714-17.
15. Cameron RJ, Kolbe J, Wilsher ML, Lambie N. Bronchiolitis obliterans organising pneumonia associated with the use of nitrofurantoin. Thorax 2000;55:249-251. http://dx.doi.org/10.1136/thorax.55.3.249
16. Travis WD, Colby TV, Koss MN, Rosado-de-Christenson ML, Muller NL, King TE. Non-Neoplastic Disorders of the Lower Respiratory Tract. In: Atlas of Nontumor Pathology Volume 2. Washington: The American Registry of Pathology, 2002. p.327.
17. Tatley M, Centre for Adverse Reactions Monitoring, Dunedin, New Zealand. (2002). Prescriber Update Articles: Pulmonary Reactions with Nitrofurantoin [online]. MEDSAFE 2002;23(2)24-5. Available: http://www.medsafe.govt.nz/profs/PUarticles/nitrofurant.htm [Accessed 2012, February 20]
18. Albert X, Huertas I, Pereiró II, Sanfélix J, Gosalbes V, Perrota C. Antibiotics for preventing recurrent urinary tract infection in non-pregnant women. Cochrane Database Syst Rev 2004;(3):CD001209. http://dx.doi.org/10.1002/14651858.CD001209.pub2
19. Epp A, Larochelle A, Lovatsis D, et al. Society of Obstetricians and Gynaecologists of Canada. Recurrent urinary tract infection. J Obstet Gynaecol Can 2010;32(11):1082-101.
20. Health Protection Agency. Management of infection guidance for primary care for consultation and local adaptation [online]. (2010). Available: http://www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1279888711402 [Accessed 2012, February 20].
21. Parker G. Failure to adequately monitor liver and lung function. MDU J 2007;23: 24-5.